Phase 2 Malignant Tumors Clinical Trials
11 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–11 of 11 trials
Recruiting
Phase 1Phase 2
Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors
Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)
Shenzhen University General Hospital20 enrolled1 locationNCT07399769
Recruiting
Phase 1Phase 2
Evaluation of the Safety, Tolerability and Efficacy of iNeo-Vac-R01, an Individualized mRNA Therapeutic Technology Based on Tumor Neoantigens, for Adjuvant Treatment in Patients With Biliary Malignant Tumors After Radical Resection
Biliary Malignant Tumors
Yifan Wang20 enrolled1 locationNCT07368803
Recruiting
Phase 1Phase 2
First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors
Advanced Malignant Tumors
Shanghai JMT-Bio Inc.436 enrolled1 locationNCT06877650
Recruiting
Phase 1Phase 2
A Study of LM-350 in Subjects With Advanced Solid Tumours
Malignant Tumors
LaNova Medicines Limited80 enrolled4 locationsNCT07112222
Recruiting
Phase 1Phase 2
Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors
Patients With Advanced or Metastatic Malignant Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.203 enrolled1 locationNCT07073534
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd468 enrolled6 locationsNCT05779163
Recruiting
Phase 1Phase 2
Study of LM-299 in Subjects Advanced Malignant Tumors
Malignant Tumors
LaNova Medicines Limited108 enrolled6 locationsNCT06650566
Recruiting
Phase 2
Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk
Biliary Malignant Tumors
The First Affiliated Hospital with Nanjing Medical University70 enrolled1 locationNCT06685289
Recruiting
Phase 1Phase 2
A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors
Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.25 enrolled1 locationNCT05991583
Recruiting
Phase 1Phase 2
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
Malignant Tumors
LaNova Medicines Limited139 enrolled5 locationsNCT05615974
Recruiting
Phase 1Phase 2
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
Advanced Malignant Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.50 enrolled1 locationNCT06223841